Investigation of Birth Planning Policy effect on parity-specific birth continuation probabilities and parental life satisfaction as a function of the numbers and gender composition of children both before and after the implementation of the BPP.
In 2013, the Bill & Melinda Gates Foundation launched two programs to help track progress toward a global goal to increase modern contraceptive use by 2020. Evaluating these programs, researchers found opportunities for improvement in four areas.
This evaluation of two programs that help monitor progress toward a global goal to increase modern contraceptive use by 2020 is based on qualitative and quantitative data from interviews with more than 260 stakeholders in 16 countries.
Among a sample of Ugandan couples with an HIV-positive partner who hope to conceive, about one-third used a "safer" conception method such as timed unprotected intercourse to reduce HIV transmission, but only about half were aware of such methods.
Proven benefits to reduced fertility — or to delayed start to childbearing and greater spacing between births — include lower maternal mortality, fewer unsafe abortions, reduced risks from early childbearing, and women's ability to engage in more income-generating opportunities.
Long-acting reversible contraceptive (LARC) methods of birth control, which include the intrauterine device and subdermal implant, are highly effective, very safe, preferable to women, and cost effective. But some states' contraceptive policies create direct and indirect barriers to LARC use.
Data on effectiveness of preexposure prophylaxis (PrEP) for human immunodeficiency virus (HIV)–uninfected women attempting conception with HIV-infected male partners are limited to observational studies.
Worldwide, nearly 800 women die every day due to mostly preventable causes related to pregnancy and childbirth. More than half of these deaths occur in fragile states torn by armed conflict and generalized violence.
Health care providers are increasingly being evaluated by the quality of care they provide. Our aim was to assess the feasibility of recently developed quality indicators (QIs) for pelvic organ prolapse (POP) and identify possible deficits in care.
This report evaluates the Population and Poverty Research Initiative (PopPov) and its progress in building economic demography, particularly policy-relevant research; policymakers’ understanding of issues; and research capacity in sub-Saharan Africa.
We developed and rated 14 potential quality indicators for the care of women with POP. Once these QIs are tested for feasibility they can be used on a larger scale to measure and compare the care provided to women with prolapse in different clinical settings.